PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Prion discovery could help keep deadly brain diseases in check

2014-01-17
(Press-News.org) Contact information: Bev Betkowski
bev.betkowski@ualberta.ca
780-492-3808
University of Alberta
Prion discovery could help keep deadly brain diseases in check New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, PhD, Case Western Reserve University School of Medicine has uncovered a quality control mechanism in brain cells that may help keep deadly neurological diseases in check for months or years.

The findings, published in The Journal of Clinical Investigation, "present a breakthrough in understanding the secret life of prion molecules in the brain and may offer a new way to treat prion diseases," said Westaway, Director of the Centre for Prions and Protein Folding Diseases and Professor of Neurology in the Faculty of Medicine and Dentistry at the University of Alberta.

Prion diseases lead to incurable neurodegenerative disorders such as Creutzfeldt-Jakob disease in humans, mad cow disease (Bovine Spongiform Encephalopathy) and chronic wasting disease in deer and elk. The diseases are caused by the conversion of normal cellular prion proteins into the diseased form.

For years, scientists have been perplexed by two unexplained characteristics of prion infections: vastly differing asymptomatic periods lasting up to five decades and when symptoms do arise, greatly varying accumulation of the diseased proteins. In striking contrast, test tube prions replicate rapidly, and in a matter of days reach levels found in brains in the final stage of the disease.

"Our study investigated the molecular mechanism of this intriguing puzzle," said Safar, Co-Director of the National Prion Disease Pathology Surveillance Center and Associate Professor in Departments of Pathology and Neurology in Case Western Reserve University School of Medicine.

In probing these mysteries, Westaway, Safar, their teams and other collaborating researchers in the U.S., Italy and the Netherlands studied a molecule called the 'shadow of the prion protein.'

"Dramatic changes in this shadow protein led us to expand our view to include the normal prion protein itself," said Westaway. "This is a crucial molecule in brain cells because it is pirated as the raw material to make diseased prion proteins."

The production and degradation of the normal prion protein had previously received little attention because it was assumed its production pipeline did not vary.

"The puzzle of the long asymptomatic time period required sorting out the different types of prion protein molecules. Our laboratory developed new techniques to tease out these subtle differences in shape," Safar said.

The researchers discovered a marked drop in the amount of the normal prion protein in eight different types of prion diseases. Strikingly, this drop occurred months or years before the animal models showed tell-tale clinical symptoms of the brain disease.

"Our belief is that cells under prion attack are smarter than we once thought," Westaway said. "They not only sense the molecular piracy by the diseased proteins, but they also adopt a simple and at least partly effective protective response – they minimize the amount raw material from the pipeline for prion production."

"We believe we can kill two birds with one stone, because the normal prion protein is also a receptor for toxicity. Augmenting this natural protective response may be a preferred route to cure prion infections," Safar added.

The study's discovery of a natural protective response can also explain the long latency period in other more common neurodegenerative diseases.

"The pre-clinical phase of the disease—before it shows symptoms—is when you want to set things straight. We may be able to take a slow disease and bring it to a complete standstill," Westaway said. "Since some scientists believe the normal prion protein is an accessory in the brain cell death of Alzheimer's disease, gaining a new understanding of rare yet lethal prion diseases may provoke fresh insights into human dementias."

### The study was funded by the Alberta Prion Research Institute, Alberta Innovates-Health Solutions, the Canada Foundation for Innovation, the US National Institutes of Health and Centers for Disease Control and Prevention, the University Health Network, and the Charles S. Britton Fund.


ELSE PRESS RELEASES FROM THIS DATE:

Loyola researchers identify risk factor for life-threatening disease in preemies

2014-01-17
Loyola researchers identify risk factor for life-threatening disease in preemies Many premature infants suffer a life-threatening bowel infection called necrotizing enterocolitis (NEC). Researchers at Loyola University Health System have identified a marker ...

Parietal gray matter volume changes may be associated with early PD memory deficits

2014-01-17
Parietal gray matter volume changes may be associated with early PD memory deficits New findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – Research by a team of investigators in Finland suggests that the free recall memory deficits common ...

Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition

2014-01-17
Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition Discovery highlights innovative and complex fermented beverages of northernmost Europe in the Bronze and Iron Ages From northwest Denmark, circa 1500-1300 BC, to the Swedish island of Gotland ...

Higher vitamin D levels associated with better cognition and mood in PD patients

2014-01-17
Higher vitamin D levels associated with better cognition and mood in PD patients Findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility ...

Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh

2014-01-17
Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh Discovery provides evidence of a forgotten Egyptian dynasty from 3,600 years ago Archaeologists working at the southern Egyptian site of Abydos have discovered the tomb of a previously ...

Big-headed fossil flies track major ecological revolution

2014-01-17
Big-headed fossil flies track major ecological revolution Simon Fraser University's Bruce Archibald and Rolf Mathewes are part of a team of biologists, including Christian Kehlmaier from Germany's Senkenberg Natural History Collections, that has discovered three new, ...

Statin use reduces delirium in critically ill patients

2014-01-17
Statin use reduces delirium in critically ill patients Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a new study of 470 intensive care patients in the UK. "This is the first ...

Vitamin D supplements reduce pain in fibromyalgia sufferers

2014-01-17
Vitamin D supplements reduce pain in fibromyalgia sufferers Researchers say Vitamin D may be cost-effective treatment or adjunct for patients with fibromyalgia syndrome and low vitamin D levels, reports PAIN® Philadelphia, January 17, 2014 – Patients with fibromyalgia ...

VHIO genomic study identifies subgroups of HER2+ breast cancer with varying sensitivities

2014-01-17
VHIO genomic study identifies subgroups of HER2+ breast cancer with varying sensitivities VHIO describes as many as 4 subgroups of HER2+ breast cancer (Luminal A, Luminal B, HER2-enriched and Basal-Like) with varying responses and benefits resulting from combined ...

2 diabetes studies in January 2014 Health Affairs

2014-01-16
2 diabetes studies in January 2014 Health Affairs January articles examine the toll of diabetes, both in the US and abroad Poorer Americans: depleted food budgets can mean higher risk of hypoglycemia. For generations, economists have noted that low-income households spend ...

LAST 30 PRESS RELEASES:

New study shows biochar’s electrical properties can influence rice field methane emissions

Guangdong faces largest chikungunya outbreak on record

Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)

An old drug, in a low dose, shown to be safe and effective in preventing progression of type 1 diabetes in children and young people (MELD-ATG trial)

Study reports potential effects of verapamil in slowing progression of type 1 diabetes

Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at 2-year follow-up

New estimates predict over 4 million missing people who would be alive in 2025 if not for inadequate type 1 diabetes care

So what should we call this – a grue jay?

Chicago Quantum Exchange-led coalition advances to final round in NSF Engine competition

Study identifies candidates for therapeutic targets in pediatric germ cell tumors

Media alert: The global burden of CVD

Study illuminates contributing factors to blood vessel leakage

What nations around the world can learn from Ukraine

Mixing tree species does not always make forests more drought-resilient

Public confidence in U.S. health agencies slides, fueled by declines among Democrats

“Quantum squeezing” a nanoscale particle for the first time

El Niño spurs extreme daily rain events despite drier monsoons in India

Two studies explore the genomic diversity of deadly mosquito vectors

Zebra finches categorize their vocal calls by meaning

Analysis challenges conventional wisdom about partisan support for US science funding

New model can accurately predict a forest’s future

‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance

Genomic evolution of major malaria-transmitting mosquito species uncovered

Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery

Tuberculosis vulnerability of people with HIV: a viral protein implicated

Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living

Decoding the selfish gene, from evolutionary cheaters to disease control

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

[Press-News.org] Prion discovery could help keep deadly brain diseases in check